Steven Weber
CIK 1844594 · Principal Accounting Officer · last filed 2025-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
14
Lifetime Open-Market Net
-$29.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLSE | Principal Accounting Officer | — | $24.37 | — | $0 | 1 | 2025-07-16 |
| IGM Biosciences, Inc. (IGMS) Delisted | PRINCIPAL ACCOUNTING OFFICER | 26,530 | $1.27 | $33.7K | -$29.8K | 11 | 2025-06-20 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | VP, Controller&Princ Acctg Off | — | $12.01 | — | $0 | 2 | 2022-02-22 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-14 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +18,750 | $0 | EDGAR |
| 2023-04-06 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +8,750 | $0 | EDGAR |
| 2022-02-22 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-19 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.